Innovative biotechnological approach utilizing engineered Yarrowia lipolytica yeast to convert fatty acid methyl esters into linear alpha olefins with controlled carbon chain lengths, promising sustainable production of valuable olefins.
This innovative research focuses on the metabolic engineering of the oleaginous yeast Yarrowia lipolytica to create a microbial cell factory capable of converting fatty acid methyl esters into linear alpha olefins. These olefins are valuable chemicals with applications in various industries, including plastics, lubricants, and surfactants. The process aims to produce olefins with specific carbon chain lengths (C8-C16), enabling tailored production for diverse industrial needs.
The core of this technology involves the genetic modification of Yarrowia lipolytica. The yeast's metabolism is optimized to efficiently degrade fatty acid methyl esters into intermediate fatty acids, which are then converted into target olefins through enhanced beta oxidation cycles. Key enzymatic steps involve:
The project is structured in phases, with the initial year focusing on engineering the metabolic pathways and subsequent years dedicated to enzyme optimization and process refinement.
Currently, this technology is at TRL 2, indicating that the concept and application have been formulated and early-stage experimental proof-of-concept activities are underway. Future efforts will be directed towards pathway validation and optimization of metabolic and bioprocess conditions to enhance production efficiency.
UT offers a partnership model that reduces risk, accelerates time-to-value, and supports long-term growth strategies for industry—providing an attractive platform for companies seeking to formalize collaboration and establish a long-term presence in the East Tennessee region. By aligning institutional investment with regional and national priorities, UT provides a stable and effective platform for industry collaboration, technology deployment, and sustained economic impact.